These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2688044)

  • 21. [Prevention of recurrent ischemic stroke: recent clinical trial results].
    Mohr JP
    Neurologia; 2002; 17(7):378-82. PubMed ID: 12236957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk factors for thromboembolism in patients with atrial fibrillation during treatment with aspirin: a multicenter, cooperative retrospective study. Research Group for Antiarrhythmic Drug Therapy].
    J Cardiol; 2000 May; 35(5):373-9. PubMed ID: 10834181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
    Lorenzoni R; Lazzerini G; Cocci F; De Caterina R
    Am Heart J; 2004 Jul; 148(1):e6. PubMed ID: 15215815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
    Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
    Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Italian Study on Atrial Fibrillation (SIFA): status report].
    Amabile G; Matteoli S; Fattapposta F; Lavezzari M; Trappolini M; Heiman F; Morocutti C
    Cardiologia; 1993 Dec; 38(12 Suppl 1):327-32. PubMed ID: 8020032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low- versus high-dose aspirin in prevention of ischemic stroke.
    Adams HP; Bendixen BH
    Clin Neuropharmacol; 1993 Dec; 16(6):485-500. PubMed ID: 9377584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination antiplatelet agents in ischemic cerebrovascular disease.
    Moussouttas M; Papamitsakis N
    Mt Sinai J Med; 2005 Jan; 72(1):16-22. PubMed ID: 15682258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antithrombotic therapy of atrial fibrillation].
    Chalon S; Lechat P
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1533-42. PubMed ID: 9092415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thromboembolic complications of arrhythmia due to atrial fibrillation].
    Lekieffre J; Lacroix D; Klug D; Kacet S
    Arch Mal Coeur Vaiss; 1994 Sep; 87 Spec No 3():17-23. PubMed ID: 7786120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and treatment of cerebrovascular accidents of cardioembolic origin].
    Ricou FJ; Arroyo JF
    Praxis (Bern 1994); 1996 Feb; 85(6):155-8. PubMed ID: 8701177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial.
    Hart RG; Bhatt DL; Hacke W; Fox KA; Hankey GJ; Berger PB; Hu T; Topol EJ;
    Cerebrovasc Dis; 2008; 25(4):344-7. PubMed ID: 18303254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
    Pengo V; De Caterina R
    Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of recurrence in cerebral infarction].
    Uchiyama S; Yamazaki M; Iwata M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():77-83. PubMed ID: 11989267
    [No Abstract]   [Full Text] [Related]  

  • 39. [The treatment of cerebrovascular disorders with anticoagulants and platelet aggregation inhibitors].
    Ameriso SF
    Rev Neurol; 1999 Dec 16-31; 29(12):1285-90. PubMed ID: 10652758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutics and arterial aging. Antiaggregants].
    Decamps A; Dartigues JF; Bourdel-Marchasson I; Manciet G; Midy D
    Ann Cardiol Angeiol (Paris); 1991 Jun; 40(6):377-84. PubMed ID: 1859145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.